Efficient Isolation of Soluble Intracellular Single-chain Antibodies using the Twin-arginine Translocation Machinery

Holliger, 2005, Engineered antibody fragments and the rise of single domains, Nature Biotechnol., 23, 1126, 10.1038/nbt1142 Bird, 1988, Single-chain antigen-binding proteins, Science, 242, 423, 10.1126/science.3140379 Huston, 1988, Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli, Proc. Natl Acad. Sci. USA, 85, 5879, 10.1073/pnas.85.16.5879 Frisch, 1996, Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain, Fold. Des., 1, 431, 10.1016/S1359-0278(96)00059-4 Kadokura, 2003, Protein disulfide bond formation in prokaryotes, Annu. Rev. Biochem., 72, 111, 10.1146/annurev.biochem.72.121801.161459 Koch, 2006, Direct selection of antibodies from complex libraries with the protein fragment complementation assay, J. Mol. Biol., 357, 427, 10.1016/j.jmb.2005.12.043 Philibert, 2004, Directed evolution of single-chain Fv for cytoplasmic expression using the beta-galactosidase complementation assay results in proteins highly susceptible to protease degradation and aggregation, Microb. Cell Fact., 3, 16, 10.1186/1475-2859-3-16 Prinz, 1997, The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm, J. Biol. Chem., 272, 15661, 10.1074/jbc.272.25.15661 Biocca, 1995, Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria, Biotechnology (NY), 13, 1110, 10.1038/nbt1095-1110 Proba, 1997, A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding, J. Mol. Biol., 265, 161, 10.1006/jmbi.1996.0726 Worn, 2000, Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors, J. Biol. Chem., 275, 2795, 10.1074/jbc.275.4.2795 Heng, 2005, Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics, J. Cell Mol. Med., 9, 191, 10.1111/j.1582-4934.2005.tb00348.x Miller, 2005, Intrabody applications in neurological disorders: progress and future prospects, Mol. Ther., 12, 394, 10.1016/j.ymthe.2005.04.003 Stocks, 2005, Intrabodies as drug discovery tools and therapeutics, Curr. Opin. Chem. Biol., 9, 359, 10.1016/j.cbpa.2005.06.003 Emadi, 2004, Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments, Biochemistry, 43, 2871, 10.1021/bi036281f Lecerf, 2001, Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease, Proc. Natl Acad. Sci. USA, 98, 4764, 10.1073/pnas.071058398 Liu, 2004, Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity, Biochemistry, 43, 9999, 10.1021/bi0492354 Paganetti, 2005, beta-site specific intrabodies to decrease and prevent generation of Alzheimer's Abeta peptide, J. Cell Biol., 168, 863, 10.1083/jcb.200410047 Cao, 2005, Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications, Ann. Clin. Lab. Sci., 35, 227 Colby, 2004, Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody, Proc. Natl Acad. Sci. USA, 101, 17616, 10.1073/pnas.0408134101 Heng, 2005, Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody), Med. Hypotheses, 64, 1105, 10.1016/j.mehy.2005.01.011 Zhu, 1999, Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7, J. Immunol. Methods, 231, 207, 10.1016/S0022-1759(99)00158-1 Gennari, 2004, Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation, J. Mol. Biol., 335, 193, 10.1016/j.jmb.2003.09.073 Grim, 1998, Intracellular expression of the anti-erbB-2 sFv N29 fails to accomplish efficient target modulation, Biochem. Biophys. Res. Commun., 250, 699, 10.1006/bbrc.1998.9391 Benhar, 2001, Biotechnological applications of phage and cell display, Biotechnol. Adv., 19, 1, 10.1016/S0734-9750(00)00054-9 Hanes, 1998, Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries, Proc. Natl Acad. Sci. USA, 95, 14130, 10.1073/pnas.95.24.14130 Feldhaus, 2003, Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library, Nature Biotechnol., 21, 163, 10.1038/nbt785 Daugherty, 1999, Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface, Protein Eng., 12, 613, 10.1093/protein/12.7.613 Ritz, 2001, Conversion of a peroxiredoxin into a disulfide reductase by a triplet repeat expansion, Science, 294, 158, 10.1126/science.1063143 Jurado, 2002, Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli, J. Mol. Biol., 320, 1, 10.1016/S0022-2836(02)00405-9 Levy, 2001, Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones, Protein Expr. Purif., 23, 338, 10.1006/prep.2001.1520 Venturi, 2002, High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm, J. Mol. Biol., 315, 1, 10.1006/jmbi.2001.5221 Bach, 2001, Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies, J. Mol. Biol., 312, 79, 10.1006/jmbi.2001.4914 Shaki-Loewenstein, 2005, A universal strategy for stable intracellular antibodies, J. Immunol. Methods, 303, 19, 10.1016/j.jim.2005.05.004 Martineau, 1996, Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein, Mol. Immunol., 33, 1345, 10.1016/S0161-5890(96)00091-0 Laden, 2002, Expression and folding of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm, Res. Microbiol., 153, 469, 10.1016/S0923-2508(02)01347-5 Martineau, 1999, In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm, J. Mol. Biol., 292, 921, 10.1006/jmbi.1999.3105 Martineau, 1998, Expression of an antibody fragment at high levels in the bacterial cytoplasm, J. Mol. Biol., 280, 117, 10.1006/jmbi.1998.1840 Auf der Maur, 2001, Antigen-independent selection of stable intracellular single-chain antibodies, FEBS Lett., 508, 407, 10.1016/S0014-5793(01)03101-5 Auf der Maur, 2004, Antigen-independent selection of intracellular stable antibody frameworks, Methods, 34, 215, 10.1016/j.ymeth.2004.04.004 Cabantous, 2005, Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein, Nature Biotechnol., 23, 102, 10.1038/nbt1044 Maxwell, 1999, A simple in vivo assay for increased protein solubility, Protein Sci., 8, 1908, 10.1110/ps.8.9.1908 Waldo, 1999, Rapid protein-folding assay using green fluorescent protein, Nature Biotechnol., 17, 691, 10.1038/10904 Wigley, 2001, Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein, Nature Biotechnol., 19, 131, 10.1038/84389 Schwalbach, 2000, Production of fluorescent single-chain antibody fragments in Escherichia coli, Protein Expr. Purif., 18, 121, 10.1006/prep.1999.1185 Philibert, 2007, A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm, BMC Biotechnol., 7, 81, 10.1186/1472-6750-7-81 Fisher, 2006, Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway, Protein Sci., 15, 449, 10.1110/ps.051902606 Ribnicky, 2007, A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding, J. Mol. Biol., 369, 631, 10.1016/j.jmb.2007.03.068 Richter, 2007, Functional Tat transport of unstructured, small, hydrophilic proteins, J. Biol. Chem., 282, 33257, 10.1074/jbc.M703303200 Bogsch, 1998, An essential component of a novel bacterial protein export system with homologues in plastids and mitochondria, J. Biol. Chem., 273, 18003, 10.1074/jbc.273.29.18003 You, 1996, Directed evolution of subtilisin E in Bacillus subtilis to enhance total activity in aqueous dimethylformamide, Protein Eng., 9, 77, 10.1093/protein/9.1.77 Zhao, 1997, Combinatorial protein design: strategies for screening protein libraries, Curr. Opin. Struct. Biol., 7, 480, 10.1016/S0959-440X(97)80110-8 Waldo, 2003, Improving protein folding efficiency by directed evolution using the GFP folding reporter, vol. 230, 343 Wu, 1970, An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity, J. Exp. Med., 132, 211, 10.1084/jem.132.2.211 Kyte, 1982, A simple method for displaying the hydropathic character of a protein, J. Mol. Biol., 157, 105, 10.1016/0022-2836(82)90515-0 de Wildt, 2000, Antibody arrays for high-throughput screening of antibody-antigen interactions, Nature Biotechnol., 18, 989, 10.1038/79494 Honegger, 2001, The influence of the buried glutamine or glutamate residue in position 6 on the structure of immunoglobulin variable domains, J. Mol. Biol., 309, 687, 10.1006/jmbi.2001.4664 de Haard, 1998, Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding, Protein Eng., 11, 1267, 10.1093/protein/11.12.1267 Jung, 2001, The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains, J. Mol. Biol., 309, 701, 10.1006/jmbi.2001.4665 Richter, 2005, Targeting of unfolded PhoA to the TAT translocon of Escherichia coli, J. Biol. Chem., 280, 42723, 10.1074/jbc.M509570200 Melchers, 1970, Eur. J. Biochem., 17, 267, 10.1111/j.1432-1033.1970.tb01163.x Lutz, 2002, A universal, vector-based system for nucleic acid reading-frame selection, Protein Eng., 15, 1025, 10.1093/protein/15.12.1025 Fromant, 1995, Direct random mutagenesis of gene-sized DNA fragments using polymerase chain reaction, Anal. Biochem., 224, 347, 10.1006/abio.1995.1050 DeLisa, 2003, Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway, Proc. Natl Acad. Sci. USA, 100, 6115, 10.1073/pnas.0937838100